Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of evodol serving as histone deacetylase inhibitor

A kind of technology of deacetylase and evodiol, which is applied in the field of medicine and can solve the problems such as evodiol and the like that have not yet been seen

Active Publication Date: 2018-07-17
JIANGSU FOOD & PHARMA SCI COLLEGE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] So far, there has been no report that Evodia lactone can be used as a histone deacetylase inhibitor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of evodol serving as histone deacetylase inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Example 1: Inhibition of Evodicarpalactone on Histone Deacetylases (HDACs)

[0014] The HDACs kit was used to test the inhibitory activity of Evodia lactone on HDACs, and SAHA was used as the positive control drug. Add bovine serum albumin, HDAC fluorescent substrate, HDACs enzymes (HDAC1, HDAC6, HDAC8) and different concentrations (1×10 -10 , 1×10 -9 , 1×10 -8 , 1×10 -7 , 1×10 -6 , 1×10 - 5 mol L -1 ) of the test compound. After reacting the test plate at 37°C for 30min, add HDAC Developer to each well, and continue to place it at 37°C for 15min, use a microplate reader to measure the fluorescence value of each well at the wavelength of 359nm and 440nm, and then compare the values ​​of each drug concentration The fluorescence values ​​at each concentration were linearly regressed to obtain the dose-response equation, and the IC of Evodia lactone and SAHA were calculated accordingly. 50 value. The results are shown in Table 1.

[0015] Table 1 The ICs of test...

Embodiment 2

[0018] Example 2: Antitumor activity of rutaecaractone

[0019] Gastric cancer BGC-3, lung cancer A549 and liver cancer HepG2 cells were selected as the test cell lines, SAHA was used as the positive control drug, and MTT method was used to evaluate the antitumor activity of evodicarpallide.

[0020] The test cell lines in the logarithmic growth phase were suspended in phenol red-free DMEM medium containing 10% fetal bovine serum, and spread into 96-well culture plates. After the cells were completely adhered to the wall, the original culture solution was discarded, and 100 μL of the culture solution containing the test drug was added (the concentration gradient was 1×10 -8 , 1×10 -7 , 1×10 -6 , 1×10 -5 , 1×10 -4 mol L -1 ) after culturing for 3 days, add 30 μL of 5 mg·mL to each well -1 MTT, continue to incubate for 4 hours in the incubator, then add 100 μL dimethyl sulfoxide to each well to dissolve, use a microplate reader to measure the absorbance value of each well ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of evodol serving as a histone deacetylase inhibitor. Research finds that the evodol is the effective inhibitor of histone deacetylase, and IC<50> values of inhibiting HDAC1, HDAC6 and HDAC8 are 0.078 micron, 0.096 micron and 2.13 microns respectively; the evodol can develop the antineoplastic activity by inhibiting the histone deacetylase, and IC<50> values ofstomach cancer BGC-3, lung cancer A549 and liver cancer HepG2 are 14.85 microns, 5.21 microns and 3.18 microns respectively.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to the use of evodia lactone as a histone deacetylase inhibitor. Background technique [0002] Evodia lactone is a compound present in the fruit of Evodia rutaecarpa (CAS No. 22318-10-1), and its structural formula is as follows: [0003] [0004] So far, there is no report that evodiolide can be used as a histone deacetylase inhibitor. Contents of the invention [0005] The object of the present invention is to provide the use of evodicarlide as a histone deacetylase inhibitor. [0006] Above-mentioned purpose of the present invention is achieved by following technical scheme: [0007] Use of evodiolide as a histone deacetylase inhibitor. [0008] The application of evodiolide in the preparation of anti-tumor medicine, food or health care product. [0009] An anti-tumor drug, food or health product, including the active ingredient evodiolide, and an acceptable carrier or excipient in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/366A61P35/00A23L33/105
CPCA23V2002/00A61K31/366A23L33/105A23V2200/308A23V2250/21
Inventor 鲍会梅
Owner JIANGSU FOOD & PHARMA SCI COLLEGE